Technical Analysis for AGN - Argenica Therapeutics Limited
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 0.725 | 3.57% | 0.025 |
AGN closed up 3.57 percent on Thursday, November 21, 2024, on 44 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 29
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 200 DMA | Bullish | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
200 DMA Resistance | Bearish | 3.57% | |
Stochastic Reached Oversold | Weakness | 3.57% | |
BB Squeeze Ended | Range Expansion | 3.57% | |
Below Lower BB | Weakness | 3.57% | |
Down 3 Days in a Row | Weakness | 3.57% | |
Lower Bollinger Band Touch | Weakness | 3.57% | |
Oversold Stochastic | Weakness | 3.57% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 10 hours ago |
Rose Above 200 DMA | about 10 hours ago |
Up 3% | about 10 hours ago |
Rose Above Lower Bollinger Band | about 11 hours ago |
200 DMA Resistance | about 11 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Argenica Therapeutics Limited researches and develops a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG007, a neuroprotective peptide candidate in pre-clinical trials for use in the protection of brain tissue against damage during a stroke. The company was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Neuroscience Stroke
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Neuroscience Stroke
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.985 |
52 Week Low | 0.415 |
Average Volume | 136,934 |
200-Day Moving Average | 0.719 |
50-Day Moving Average | 0.741 |
20-Day Moving Average | 0.744 |
10-Day Moving Average | 0.742 |
Average True Range | 0.033 |
RSI (14) | 45.95 |
ADX | 17.9 |
+DI | 20.243 |
-DI | 22.104 |
Chandelier Exit (Long, 3 ATRs) | 0.726 |
Chandelier Exit (Short, 3 ATRs) | 0.791 |
Upper Bollinger Bands | 0.788 |
Lower Bollinger Band | 0.700 |
Percent B (%b) | 0.29 |
BandWidth | 11.777 |
MACD Line | -0.006 |
MACD Signal Line | -0.001 |
MACD Histogram | -0.0046 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.755 | ||||
Resistance 3 (R3) | 0.753 | 0.742 | 0.750 | ||
Resistance 2 (R2) | 0.742 | 0.734 | 0.743 | 0.748 | |
Resistance 1 (R1) | 0.733 | 0.729 | 0.738 | 0.735 | 0.747 |
Pivot Point | 0.722 | 0.722 | 0.724 | 0.723 | 0.722 |
Support 1 (S1) | 0.713 | 0.714 | 0.718 | 0.715 | 0.703 |
Support 2 (S2) | 0.702 | 0.709 | 0.703 | 0.702 | |
Support 3 (S3) | 0.693 | 0.702 | 0.700 | ||
Support 4 (S4) | 0.695 |